JPRN-jRCT2080220904未知3 期
Phase 3, multicenter, open-label study to evaluate the safety and efficacy of long-term administration of TAK-085 to the patients with hypertriglyceridemia
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 75age old（—）
- 性别
- All
入选标准
- •Subjects diagnosed with hypertriglyceridemia, etc.
排除标准
- •1. Subject had coronary artery disease
- •2. Subject received aortic aneurysmectomy
- •3. Subject had hemorrhagic disease etc.
研究者
相似试验
进行中（未招募）
1 期
An experimental study in men with prostate cancer to investigate the drug Zoreline 10.8 mg on its effects on the human body and safety.Prostate cancerEUCTR2013-000799-14-BEovalon S. A.142
进行中（未招募）
1 期
An experimental study in men with prostate cancer to investigate the drug Zoreline 10.8 mg on its effects on the human body and safety.Prostate cancerEUCTR2019-000593-32-DEovalon S.A.142
已完成
3 期
Phase III, open-label, multi-center study to assess the pharmacodynamic (PD), pharmacokinetic (PK) and safety of Zoreline 10.8 mg goserelin subcutaneous implant (Novalon) in male patients with prostate cancerprostate adenocarcinoma10038597prostate cancerNL-OMON42816ovalon S.A.12
进行中（未招募）
1 期
An experimental study in men with prostate cancer to investigate the drug Zoreline 10.8 mg on its effects on the human body and safety.MedDRA version: 18.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Prostate cancerEUCTR2013-000799-14-NLovalon S. A.142
进行中（未招募）
1 期
Phase III, open-label, multi-centre study to investigate the movement, effect and safety of Zoreline 3.6 mg goserelin implant (Novalon) injected under skin, in women with confirmed endometriosisMedDRA version: 19.0Level: PTClassification code 10014778Term: EndometriosisSystem Organ Class: 10038604 - Reproductive system and breast disordersEndometriosisEUCTR2013-000798-59-HUovalon S.A142